Clinical Trials on Urological Disease

Total 378695 results

Samsung Medical Center

Completed

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity

Nocturia

Korea, Republic of
Metropolis Medical
Merck Sharp & Dohme LLC

Completed

Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria (RALPIR)

HIV Infections | Proteinuria
University Hospital, Ghent

Completed

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study

Nocturia

Belgium
University Hospital, Ghent

Completed

Watershift - Pilot Study (WATERSHIFT)

Nocturnal Polyuria | Total Body Water

Belgium
Ferring Pharmaceuticals

Completed

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

Nocturia

Japan
Ferring Pharmaceuticals

Completed

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects

Nocturia

Japan
National Taiwan University Hospital

Completed

Prevalence and Risk Factors Nocturnal Polyuria in Female OAB

Nocturia
University Medical Centre Ljubljana
Abbott

Completed

Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients

Proteinuria | Albuminuria | Disorder of Transplanted Kidney

Slovenia
Sonderborg Hospital

Completed

Sensitivity and Specificity of Urinary Dipstick in Emergency Departments

Proteinuria

Denmark
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Proteinuria | Nephrotic Syndrome

United States
Sir Mortimer B. Davis - Jewish General Hospital
Cancer Research Network

Terminated

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Bladder Carcinoma | BCG

Canada
Allergan

Completed

Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

Urinary Bladder, Overactive

United States
FemPulse Corporation

Completed

FemPulse Therapy First-in-Human Experience

Urinary Bladder, Overactive

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
National Taiwan University Hospital

Completed

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

Urinary Bladder, Overactive
Astellas Pharma Inc

Completed

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Urinary Bladder, Overactive

Sweden, United Kingdom, Belgium, Denmark
Pfizer

Completed

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

Urinary Bladder, Overactive

Singapore
KYU-SUNG LEE
Astellas Pharma Korea, Inc.

Completed

A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder

Urinary Bladder, Overactive

Korea, Republic of
Astellas Pharma Inc

Completed

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder (VERSUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate Versus Tolterodine 4mg Once Daily (STAR)

Urinary Bladder, Overactive

France, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
Pfizer

Completed

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Urinary Bladder, Overactive

Portugal
Pfizer

Terminated

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

Urinary Bladder, Overactive
Pfizer

Completed

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Urinary Bladder, Overactive
Rambam Health Care Campus

Unknown

Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms

Urinary Bladder, Overactive

Israel
Pamukkale University

Recruiting

The Efficacy of Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

Urinary Bladder, Overactive

Turkey
Janaina Mayer de Oliveira Nunes

Terminated

Electrostimulation in the Treatment of Idiopathic Overactive Bladder

Urinary Bladder, Overactive
Centre Hospitalier Universitaire de Nīmes

Completed

Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder (HAVIR Bi)

Urinary Bladder, Overactive

France
Pfizer

Completed

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Urinary Bladder, Overactive

Canada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
Allergan

Completed

Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Urinary Bladder, Overactive

Japan
Astellas Pharma Inc

Completed

Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms (VOLT)

Urinary Bladder, Overactive

United States
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants

Urinary Bladder, Overactive
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
Pfizer

Completed

The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Urinary Bladder, Overactive

United States
Pamukkale University

Not yet recruiting

Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder

Urinary Bladder, Overactive

Turkey
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics and Relative Bioavailability Study

Urinary Bladder, Overactive

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Urinary Bladder, Overactive

United States
FemPulse Corporation

Unknown

FemPulse Therapy for Overactive Bladder in Women (EVANESCE-OAB)

Urinary Bladder, Overactive

United States
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 (LEOPARD)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
Federal University of Health Science of Porto Alegre

Unknown

Effects of TENS in Autonomous System in Women With Overactive Bladder

Urinary Bladder, Overactive

Brazil
Astellas Pharma Inc

Completed

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) (VENUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (SUNRISE)

Urinary Bladder, Overactive

France, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
Uroplasty, Inc

Completed

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms (STEP)

Urinary Bladder, Overactive

United States
Clínica Infantil Colsubsidio

Unknown

Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review

Urinary Bladder, Overactive

Colombia
EMKinetics, Inc

Terminated

Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder

Urinary Bladder, Overactive

United States
Pfizer

Completed

UK Study Assessing Flexible Dose Fesoterodine in Adults (SAFINA)

Urinary Bladder, Overactive

United Kingdom
Pfizer

Completed

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Urinary Bladder, Overactive

Korea, Republic of
Savino M. Di Stasi
University of Bari

Completed

Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms (Baobab)

Lower Urinary Tract Symptoms | Superficial Bladder Cancer

Italy

3

Subscribe